US-based medical technology companies GE HealthCare and Biofourmis have teamed up to enhance the continuity of care by providing safe, effective, and accessible care at home.

The collaboration will leverage the combined expertise of the two companies to scale and deliver advanced, care-at-home solutions.

Care-at-home programs comprise a virtual component and are effective in shortening the hospital stay and readmission rates which may help reduce the overall cost of care.

In addition, care-at-home programs can also support patient recovery and safety, with a potential reduction in fall risk and hospital-acquired infections.

The collaboration aims to enable more patients to go home earlier and provide an alternative to facility-based care with comfort and peace of mind.

Biofourmis’ FDA-approved, AI-guided algorithms will provide insights that help care teams deliver effective personalised care at home.

The company also offers care-at-home solutions such as FDA-approved AI algorithms, clinical-grade wearable devices, in-home services orchestration technology, and nursing services.

GE HealthCare’s FlexAcuity monitoring solutions, together with virtual care solutions like Mural ICU, Command Center and Digital CMU adapt to rapidly changing patient needs in the hospital.

Under the partnership, GE HealthCare will offer Biofourmis’ virtual care-at-home solutions to customers to extend their care continuum beyond the hospital.

GE HealthCare will begin distributing Biofourmis solutions in the US starting from Q1 2024.

GE HealthCare executive Ashutosh Banerjee said: “Biofourmis’ demonstrated success with care-at-home solutions will extend GE HealthCare’s current inpatient monitoring portfolio to support patient care from the hospital to home.

“Combining our companies’ demonstrated capabilities will help revolutionize the way we approach the patient care journey as well as help address current challenges faced by health systems including hospital capacity issues and clinical staffing shortages.”

Biofourmis Care general manager Ross Armstrong said: “Our collaboration will enable health systems and hospitals to leverage the power of technology and data in order to shape patient-focused solutions across the care continuum, no matter where the site of care is.”

In a separate development, GE HealthCare announced that New Jersey-based Virtua Health has installed its Omni Legend digital PET/CT system and Revolution Apex platform.

Virtua Health is a non-profit healthcare system based in southern New Jersey that operates a chain of hospitals, surgery centres, and physician practices.

The Omni Legend PET/CT is an advanced technology intended to harness the power of an advanced digital detector producing high-resolution images and superior image quality.

The system delivers more than two times the sensitivity of prior digital scanners with a similar axial field of view, to enable faster total scan times and increased small lesion detectability.

Revolution Apex platform is designed to produce high-quality CT images using TrueFidelity, an image reconstruction technology that leverages Deep Neural Network to generate high-definition, low-noise CT images.

Virtua Health has added the Omni Legend PET/CT system and Revolution Apex platform to enhance the capabilities of its cardiology facility in Moorestown, New Jersey.

Virtua cardiologist Mark Finch said: “The highest quality of cardiovascular ima

Set featured image

ging matters because it helps us more accurately diagnose a patient’s heart condition.

“From there, we can establish the best possible care pathway, whether that’s medication, lifestyle modification, or medical intervention. The more information we’re able to analyze, the better our patient outcomes can become.

“That’s why we’re excited to add these innovative GE HealthCare systems to our facility and help improve quality of life for those we care for.”